Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial - Antoniotti, C; Rossini, D; Pietrantonio, F (Lancet Oncol, 2022)
et al.